176 related articles for article (PubMed ID: 4874408)
1. [Damage to eyes through conservative therapy].
Kleberger E
Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408
[No Abstract] [Full Text] [Related]
2. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
3. Ocular complications of phenothiazines.
Mathalone MB
Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
[No Abstract] [Full Text] [Related]
4. Effects of drugs on cornea, conjunctiva, and lids.
Goldstein JH
Int Ophthalmol Clin; 1971; 11(2):13-34. PubMed ID: 4948449
[No Abstract] [Full Text] [Related]
5. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
[No Abstract] [Full Text] [Related]
6. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
Francesconi G; Di Tizio A; Cameo D
Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
[No Abstract] [Full Text] [Related]
7. Incidence and significance of chlorpromazine-induced eye changes.
De Long SL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
[No Abstract] [Full Text] [Related]
8. Prognosis of eye complications caused by phenothiazines.
Forrest FM; Snow HL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
[No Abstract] [Full Text] [Related]
9. [Drug influences on the visual organs and traffic].
Gramberg-Danielsen B
Ophthalmologica; 1969; 158 Suppl():410-6. PubMed ID: 5359742
[No Abstract] [Full Text] [Related]
10. Ocular adverse effects of neuropsychiatric agents. Incidence and management.
Oshika T
Drug Saf; 1995 Apr; 12(4):256-63. PubMed ID: 7646824
[TBL] [Abstract][Full Text] [Related]
11. [Undesirable adverse effects of the antirheumatic pharmacotherapy on the eyes].
Verraz R
Arch Sci Med (Torino); 1974; 131(3):167-72. PubMed ID: 4463933
[No Abstract] [Full Text] [Related]
12. Some iatrogenic ocular diseases from systemically administered drugs.
Bernstein HN
Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
[No Abstract] [Full Text] [Related]
13. Ocular complications of drug therapy.
Tredici TJ; Epstein DL
Aerosp Med; 1972 Aug; 43(8):898-902. PubMed ID: 4403460
[No Abstract] [Full Text] [Related]
14. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
[No Abstract] [Full Text] [Related]
15. [Dangers of various recent ophthalmologic drugs].
Casanovas J; Casanovas R
Ann Ocul (Paris); 1969 Jan; 202(1):1-22. PubMed ID: 4239823
[No Abstract] [Full Text] [Related]
16. [Ocular lesions caused by phenothiazines].
Delorme R; Ballereau L; Baïkoff G; Quéré MA
Bull Soc Ophtalmol Fr; 1973 Apr; 73(4):591-3. PubMed ID: 4152702
[No Abstract] [Full Text] [Related]
17. [Ophthalmological side effects of systemically administered drugs].
Calissendorff B
Lakartidningen; 1977 Nov; 74(47):4215-7. PubMed ID: 926950
[No Abstract] [Full Text] [Related]
18. Ocular accumulation and toxicity of certain systemically administered drugs.
Mason CG
J Toxicol Environ Health; 1977 May; 2(5):977-95. PubMed ID: 405503
[TBL] [Abstract][Full Text] [Related]
19. Toxic effects of phenothiazines on the eye.
Boet DJ
Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
[No Abstract] [Full Text] [Related]
20. Ocular melanosis with special reference to chlorpromazine.
Cameron ME
Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
